Table 3.
Population coverage results for the peptide DVWTYNAELLVLMEN and NGNFIAPEYAYKIVK
Population/area | Combined coverage of DVWTYNAELLVLMEN | Combined coverage of NGNFIAPEYAYKIVK |
---|---|---|
Central Africa | 100.0% | 90.3% |
Central America | 99.96% | 22.49% |
East Africa | 100.0% | 84.31% |
East Asia | 92.54% | 65.42% |
Europe | 100.0% | 99.87% |
North Africa | 99.17% | 38.03% |
North America | 100.0% | 99.95% |
Northeast Asia | 100.0% | 93.59% |
Oceania | 100.0% | 91.01% |
South Africa | 11.65% | 45.75% |
South America | 99.95% | 95.51% |
South Asia | 100.0% | 98.85% |
Southeast Asia | 69.34% | 65.03% |
Southwest Asia | 99.72% | 49.6% |
West Africa | 100.0% | 92.84% |
West Indies | 5.69% | 27.65% |
World | 99.73% | 94.64% |